Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
XLRN | ACCELERON PHARMA INC | SVP, General Counsel and Sec. | Nov 19, 2021 | |||
CYT | Cyteir Therapeutics, Inc. | General Counsel | Feb 3, 2023 | |||
DNTH | Dianthus Therapeutics, Inc. /DE/ | SVP, General Counsel and Sec. | May 23, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|